Wednesday, July 8, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “sodium chloride” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 38
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 38 pipeline programs matching "sodium chloride" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

38 results for “sodium chloride” Back to intelligence hub

Search results

Page 2 of 2
  1. SODIUM CHLORIDE SOLUTION 0.9%, mRNA-1345

    Moderna Biotech Spain

    Respiratory syncytial virus

    phase 2 small molecule active

    1 trial
  2. SODIUM CHLORIDE, ARO-DUX4

    Sarepta Therapeutics

    Facioscapulohumeral muscular dystrophy (FSHD)

    phase 2 small molecule active

    1 trial
  3. SODIUM CHLORIDE, ENTR-601-45

    Entrada Therapeutics

    Duchenne Muscular Dystrophy

    phase 2 small molecule active

    1 trial
  4. Sodium Chloride 0.9% w/v Intravenous Infusion...

    Disc Medicine

    aneurysmal subarachnoid hemorrhage

    phase 2 small molecule active

    1 trial
  5. Sodium chloride Fresenius Kabi 0 for Cerebral Autosomal Dominant Art…

    Lacuna Pharma Pty Ltd

    Cerebral Autosomal Dominant Arteriopathy with subcortical Infarcts and Leukoencephalopathy (CADASIL)

    phase 2 small molecule active

    1 trial
  6. 0.9% Sodium Chloride Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Unstable Angina

    approved small molecule active

    1 trial
  7. HUMAN SERUM ALBUMIN, SODIUM CHLORIDE

    The George Institute

    descompensated hepatic cirrosis

    approved small molecule active

    1 trial
  8. ROPIVACAINE , SODIUM CHLORIDE

    Disc Medicine

    Urolithiasis

    approved small molecule active

    1 trial
  9. SODIUM CHLORIDE, ROPIVACAINE HYDROCHLORIDE

    Disc Medicine

    Total Hip Arthroplasty / THA

    approved small molecule active

    1 trial
  10. Sodium Chloride 0.9% for Vulvar High-Grade Squamous Intr…

    Disc Medicine

    Vulvar High-Grade Squamous Intraepithelial Lesion (vHSIL)

    approved small molecule active

    1 trial
  11. Sodium Chloride Fresenius Kabi Italia 0 for Systemic sclerosis

    Disc Medicine

    Systemic sclerosis

    approved small molecule active

    1 trial
  12. Sodium Chloride Fresenius Kabi Italia 0.9 % S...

    Disc Medicine

    Fibrous dysplasia/McCune-Albright syndrome

    approved small molecule active

    1 trial
  13. Tirofiban hydrochloride sodium chloride injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Branch Atheromatous Disease

    approved small molecule completed

    1 trial
  14. Dextrometropine and 0.9% sodium chloride solution

    The First People's Hospital of Lianyungang

    Cataract

    small molecule active

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.